NFKB1 and COVID-19: DPP-4 themselves directly promote T cell proliferation, CD86 expression, activation of the NF-κB signaling pathway and excessive production of inflammatory cytokines to lead to an imbalance of inflammation [9, 24], while severe cases of COVID-19 are characterized by excessive inflammation and the substantial production of pro-inflammatory factors [25, 26].